Board of Directors

image325

Chairman of the Board

Chief Executive Officer & Director

Chief Executive Officer & Director

  • Executive for over 20 years at Johnson & Johnson Consumer Companies (NYSE:JNJ), the world’s largest and most diversified healthcare company with worldwide sales of US$76 billion in 2017. 
  • In his role as Johnson & Johnson Company Chairman for Consumer North America, his division represented more than 42% of global revenue. 
  • As President of Johnson & Johnson’s largest business unit, Jeff grew it from the 3rd largest skincare company to #1 in the U.S. over 3.5 years. 

image326

Chief Executive Officer & Director

Chief Executive Officer & Director

Chief Executive Officer & Director

  • Serial entrepreneur with over two decades of experience in capital markets
  • Co-founder, President and CEO of the Yield Growth Corp. (CSE: BOSS) 3 years
  • Initial officer & director for 2 years of Merus Labs Inc. (TSX:MSL), which was acquired by Norgine B.V. in 2017 for $342 million 
  • Recognized in PROFIT Magazine's W100 most successful entrepreneurs and her private company was included in PROFIT 500 Fastest Growing companies in 2015 and 2016 based on revenues

image327

Director

Chief Executive Officer & Director

Director

  • Over 15 years of experience with consumer product companies, including acting as in-house counsel during billion-dollar IPO’s at Aritzia (TSX: ATZ) and Sketchers (NYSE:SKX)
  • Associate General Counsel of Skechers USA Inc. ,when annual revenues increased approximately 50% ($675M to $1.006B) and the share price increased over 300%. 
  • Co-General Counsel at Aritzia LP, annual revenues increased approximately 100%, from under $400M to $743M. 
  • Expertise includes negotiating inbound and outbound licensing, intellectual property strategies and portfolio management, corporate governance for private and public US and Canadian companies, as well as a wide breadth of commercial matters, including distribution agreements and technology contracts.

Management Team

image328

Chief Operating Officer

Chief Operating Officer

Chief Operating Officer

  • Proven expertise in scaling operations; she was instrumental in the growth of Canadian fashion retailer Aritzia (TSX:ATZ) as its Vice President, Corporate Operations and Executive Vice President, People & Culture. 
  • Built several of the corporate backend functions from scratch, helping Aritzia to scale its operations and achieve $743M in annual revenue and to reach a market capitalization of over $1 billion when she left in 2017. 
  • Member and former chair of the Executive Committee of Aritzia, directly led and oversaw numerous cross-functional projects to build the necessary infrastructure to enable growth.

image329

Vice President, Sales

Chief Operating Officer

Chief Operating Officer

  • Seasoned sales broker bringing decades of experience working with distributors to grow a multitude of brands in the skincare, edible mushrooms and other wellness spaces 
  • Past experience includes Lavido Skin Care, Love Chock, My Matcha Life, Four Sigmatic, Sun Warrior, Mikei Red Reishi, Thursday Plantation and Kosmea Skin Care. 
  • Expansion and long standing relationships with skincare and wellness retail distributors cultivated over 15 years in the profession.

image330

Advisor

Chief Operating Officer

Advisor

  • Over 20 years of experience as a patent lawyer in the preparation and prosecution of patent applications in a variety of industries including: biotechnology, chemistry, biofuel, oil and gas and pharmaceuticals.
  • In addition to designing and filing patent applications, Charles provides his clients with IP due diligence, validity, and freedom to operate opinions.
  • Experience drafting and negotiating license agreements and advises on food and drug regulatory law, including product labelling and advertising.

Scientific Advisory

image331

Chair, Scientific Advisory Board

  • Dually boarded Neurologist and Psychiatrist and Canadian Institute of Health Research funded academic faculty at the University of British Columbia.
  • Completed a post doctoral fellowship at UBC and Harvard University. 
  • Maintains an internationally recognized research program in brain injury, mental health and addictions. 
  • Authored over 30 publications in the last 5 years. 

Subscribe

For investor information and updates on NeonMind Biosciences, sign up here